Investors urge climate-style action against antimicrobial resistance

Investors managing over $13 trillion are urging global policymakers to establish science-based targets to combat antimicrobial resistance (AMR), which kills approximately 1.3 million people annually. A recent report warns that unchecked AMR could result in $1 trillion in healthcare costs and 10 million deaths per year by 2050. The initiative, backed by 80 institutions, seeks an international framework similar to the Paris Agreement on climate change.